Relaxin-3 stimulates the neuro-endocrine stress axis via corticotrophin-releasing hormone

Journal of Endocrinology

Volumn 221, Issue 2, 2014, Pages 337-346

  McGowan, B M ^a   Minnion, J S ^b   Murphy, K G ^b   Roy, D ^b   Stanley, S A ^c   Dhillo, W S ^b   Gardiner, J V ^b   Ghatei, M A ^b   Bloom, S R ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

ACTH; Corticosterone; Paraventricular nucleus; Relaxin 3; RXFP1; RXFP3

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; PROLACTIN; PROTEIN C FOS; RELAXIN 3; NERVE PROTEIN; RELAXIN; RELAXIN 3, RAT; RELAXIN-3, RAT;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DOSE RESPONSE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; REPRODUCTION; SIGNAL TRANSDUCTION; STRESS; ANIMAL; DOWN REGULATION; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; NEUROSECRETION; PARAVENTRICULAR NUCLEUS; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RELAXIN-3; RXFP1; RXFP3; WISTAR RAT;

ACTH; CORTICOSTERONE; PARAVENTRICULAR NUCLEUS; RELAXIN-3; RXFP1; RXFP3;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOWN-REGULATION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENTRICULAR; MALE; NERVE TISSUE PROTEINS; NEUROSECRETORY SYSTEMS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; RELAXIN; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84903545762     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0603     Document Type: Article

References (51)

1. Banerjee A, Shen PJ, Ma S, Bathgate RA & Gundlach AL 2010 Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 58 145-155. (doi:10.1016/j.neuropharm.2009.06.019)
2. Bartanusz V, Aubry JM, Jezova D, Baffi J & Kiss JZ 1993 Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress. Neuroendocrinology 58 625-629. (doi:10.1159/000126602)
3. Bathgate RA, Samuel CS, Burazin TC, Layfield S, Claasz AA, Reytomas IG, Dawson NF, Zhao C, Bond C, Summers RJ et al. 2002 Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. Journal of Biological Chemistry 277 1148-1157. (doi:10.1074/jbc.M107882200)
4. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD & Summers RJ 2005 Receptors for relaxin family peptides. Annals of the New York Academy of Sciences 1041 61-76. (doi:10.1196/annals.1282.010)
5. Beak SA, Heath MM, Small CJ, Morgan DG, Ghatei MA, Taylor AD, Buckingham JC, Bloom SR & Smith DM 1998 Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. Journal of Clinical Investigation 101 1334-1341. (doi:10.1172/JCI610)
6. Buckingham JC & Hodges JR 1977 The use of corticotrophin production by adenohypophysial tissue in vitro for the detection and estimation of potential corticotrophin releasing factors. Journal of Endocrinology 72 187-193. (doi:10.1677/joe.0.0720187)
7. Burazin TC, Bathgate RA, Macris M, Layfield S, Gundlach AL & Tregear GW 2002 Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. Journal of Neurochemistry 82 1553-1557. (doi:10.1046/j.1471-4159.2002.01114.x)
8. Burazin TC, Johnson KJ, Ma S, Bathgate RA, Tregear GW & Gundlach AL 2005 Localization of LGR7 (relaxin receptor) mRNA and protein in rat forebrain: correlation with relaxin binding site distribution. Annals of the New York Academy of Sciences 1041 205-210. (doi:10.1196/annals. 1282.031)
9. Chen J, Kuei C, Sutton SW, Bonaventure P, Nepomuceno D, Eriste E, Sillard R, Lovenberg TW & Liu C 2005 Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species. Journal of Pharmacology and Experimental Therapeutics 312 83-95. (doi:10.1124/jpet.104.073486)
10. Engler D, Pham T, Fullerton MJ, Ooi G, Funder JW & Clarke IJ 1989 Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. Neuroendocrinology 49 367-381. (doi:10.1159/ 000125141)
11. Freeman ME, Kanyicska B, Lerant A & Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiological Reviews 80 1523-1631.
12. Ganella DE, Ryan PJ, Bathgate RA & Gundlach AL 2012 Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications. Behavioural Pharmacology 23 516-525. (doi:10.1097/FBP.0b013e3283576999)
13. Ganella DE, Callander GE, Ma S, Bye CR, Gundlach AL & Bathgate RA 2013a Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus. Gene Therapy 20 703-716. (doi:10.1038/gt.2012.83)
14. Ganella DE, Ma S & Gundlach AL 2013b Relaxin-3/RXFP3 signaling and neuroendocrine function-a perspective on extrinsic hypothalamic control. Frontiers in Endocrinology 4 128. (doi:10.3389/fendo.2013.00128)
15. Goto M, Swanson LW & Canteras NS 2001 Connections of the nucleus incertus. Journal of Comparative Neurology 438 86-122. (doi:10.1002/ cne.1303)
16. Herman JP 1995 In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. Journal of Comparative Neurology 363 15-27. (doi:10.1002/cne.903630103)
17. Hudson P, Haley J, John M, Cronk M, Crawford R, Haralambidis J, Tregear G, Shine J & Niall H 1983 Structure of a genomic clone encoding biologically active human relaxin. Nature 301 628-631. (doi:10.1038/301628a0)
18. Hudson P, John M, Crawford R, Haralambidis J, Scanlon D, Gorman J, Tregear G, Shine J & Niall H 1984 Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones. EMBO Journal 3 2333-2339.
19. Kennett JE & McKee DT 2012 Oxytocin: an emerging regulator of prolactin secretion in the female rat. Journal of Neuroendocrinology 24 403-412. (doi:10.1111/j.1365-2826.2011.02263.x)
20. Krajnc-Franken MA, van Disseldorp AJ, Koenders JE, Mosselman S, van Duin M & Gossen JA 2004 Impaired nipple development and parturition in LGR7 knockout mice. Molecular and Cellular Biology 24 687-696. (doi:10.1128/MCB.24.2.687-696.2004)
21. Lenglos C, Mitra A, Guevremont G & Timofeeva E 2013 Sex differences in the effects of chronic stress and food restriction on body weight gain and brain expression of CRF and relaxin-3 in rats. Genes, Brain, and Behavior 12 370-387. (doi:10.1111/gbb.12028)
22. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, Farmer N, Jornvall H, Sillard R & Lovenberg TW 2003a Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. Journal of Biological Chemistry 278 50754-50764. (doi:10.1074/jbc.M308995200)
23. Liu C, Chen J, Sutton S, Roland B, Kuei C, Farmer N, Sillard R & Lovenberg TW 2003b Identification of relaxin-3/INSL7 as a ligand for GPCR142. Journal of Biological Chemistry 278 50765-50770. (doi:10.1074/jbc.M308996200)
24. Ma S, Shen PJ, Burazin TC, Tregear GW & Gundlach AL 2006 Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1)mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action? Neuroscience 141 329-344. (doi:10.1016/j.neuroscience.2006.03.076)
25. Ma S, Olucha-Bordonau FE, Hossain MA, Lin F, Kuei C, Liu C, Wade JD, Sutton SW, Nunez A & Gundlach AL 2009 Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learning & Memory 16 730-742. (doi:10.1101/lm.1438109)
26. Maixnerova J, Spolcova A, Pychova M, Blechova M, Elbert T, Rezacova M, Zelezna B & Maletinska L 2011 Characterization of prolactin-releasing peptide: binding, signaling and hormone secretion in rodent pituitary cell lines endogenously expressing its receptor. Peptides 32 811-817. (doi:10.1016/j.peptides.2010.12.011)
27. Matsumoto M, Kamohara M, Sugimoto T, Hidaka K, Takasaki J, Saito T, Okada M, Yamaguchi T & Furuichi K 2000 The novel G-protein coupled receptor SALPR shares sequence similarity with somatostatin and angiotensin receptors. Gene 248 183-189. (doi:10.1016/S0378-1119(00)00123-2)
28. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, Gardiner JV, Murphy KG, Ghatei MA & Bloom SR 2005 Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146 3295-3300. (doi:10.1210/en.2004-1532)
29. McGowan BM, Stanley SA, Smith KL, Minnion JS, Donovan J, Thompson EL, Patterson M, Connolly MM, Abbott CR, Small CJ et al. 2006a Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regulatory Peptides 136 72-77. (doi:10.1016/ j.regpep.2006.04.009)
30. McGowan BM, Stanley SA, White NE, Spangeus A, Patterson M, Thompson EL, Smith KL, Donovan J, Gardiner JV, Ghatei MA et al. 2006b Hypothalamic mapping of orexigenic action and fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. American Journal of Physiology. Endocrinology and Metabolism 292 E913-E919. (doi:10.1152/ajpendo.00346.2006)
31. McGowan BM, Stanley SA, Donovan J, Thompson EL, Patterson M, Semjonous NM, Gardiner JV, Murphy K, Ghatei MA & Bloom SR 2008 Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. American Journal of Physiology. Endocrinology and Metabolism 295 E278-E286. (doi:10.1152/ajpendo.00028.2008)
32. Muller MB, Landgraf R, Preil J, Sillaber I, Kresse AE, Keck ME, Zimmermann S, Holsboer F & WurstW2000 Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin- releasing hormone receptor 1 is dependent on glucocorticoids. Endocrinology 141 4262-4269. (doi:10.1210/endo.141.11.7767)
33. Noel GL, Suh HK, Stone JG & Frantz AG 1972 Human prolactin and growth hormone release during surgery and other conditions of stress. Journal of Clinical Endocrinology and Metabolism 35 840-851. (doi:10.1210/jcem-35-6-840)
34. Paxinos G & Watson C 1998 In The Rat Brain in Stereotactic Co-ordinates, 4th edn. San Diego, CA, USA: Academic.
35. Plotsky PM, Bruhn TO & Vale W 1985 Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 117 323-329. (doi:10.1210/endo-117-1-323)
36. Robinson DA, Wei F, Wang GD, Li P, Kim SJ, Vogt SK, Muglia LJ & Zhuo M 2002 Oxytocin mediates stress-induced analgesia in adult mice. Journal of Physiology 540 593-606. (doi:10.1113/jphysiol.2001.013492)
37. Ryan PJ, Buchler E, Shabanpoor F, Hossain MA, Wade JD, Lawrence AJ & Gundlach AL 2013a Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat. Behavioural Brain research 244 142-151. (doi:10.1016/j.bbr.2013.01.034)
38. Ryan PJ, Kastman HE, Krstew EV, Rosengren KJ, Hossain MA, Churilov L, Wade JD, Gundlach AL & Lawrence AJ 2013b Relaxin-3/RXFP3 system regulates alcohol-seeking. PNAS 110 20789-20794. (doi:10.1073/pnas.1317807110)
39. Shin SH 1982 Vasopressin has a direct effect on prolactin release in male rats. Neuroendocrinology 34 55-58. (doi:10.1159/000123277)
40. Soloff MS, Gal S, Hoare S, Peters CA, Hunzicker-Dunn M, Anderson GD & Wood TG 2003 Cloning, characterization, and expression of the rat relaxin gene. Gene 323 149-155. (doi:10.1016/j.gene.2003.09.015)
41. Stanley SA, Small CJ, Kim MS, Heath MM, Seal LJ, Russell SH, Ghatei MA & Bloom SR 1999 Agouti related peptide (Agrp) stimulates the hypothalamo pituitary gonadal axis in vivo & in vitro in male rats. Endocrinology 140 5459-5462. (doi:10.1210/endo.140.11.7248)
42. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA & Hsueh AJ 2003 H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. Journal of Biological Chemistry 278 7855-7862. (doi:10.1074/jbc.M212457200)
43. Sutton SW, Bonaventure P, Kuei C, Roland B, Chen J, Nepomuceno D, LovenbergTW & Liu C 2004 Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology 80 298-307. (doi:10.1159/000083656)
44. Sutton SW, Bonaventure P, Kuei C, Nepomuceno D, Wu J, Zhu J, Lovenberg TW & Liu C 2005 G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135. Neuroendocrinology 82 139-150. (doi:10.1159/000091267)
45. Tanaka M, Iijima N, Miyamoto Y, Fukusumi S, Itoh Y, Ozawa H & Ibata Y 2005 Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. European Journal of Neuroscience 21 1659-1670. (doi:10.1111/j.1460-9568.2005.03980.x)
46. Volpi S, Rabadan-Diehl C & Aguilera G 2004 Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation. Stress 7 75-83. (doi:10.1080/10253890410001733535)
47. Ward H, Gardiner J, Kong WM, Murphy K & Bloom S 2003 Distribution of fluorescence following injection of recombinant adeno-associated virus encoding green fluorescent protein into the paraventricular nucleus. Neuroendocrinology 77 100-104. (doi:10.1159/000068651)
48. Watanabe Y, Miyamoto Y, Matsuda T & Tanaka M 2011 Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. Journal of Molecular Neuroscience 43 169-174. (doi:10.1007/s12031-010-9468-0)
49. van der Westhuizen ET, Christopoulos A, Sexton PM, Wade JD & Summers RJ 2010 H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3). Molecular Pharmacology 77 759-772. (doi:10.1124/mol.109.061432)
50. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA et al. 2001 Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 2540-2547. (doi:10.2337/diabetes.50.11.2540)
51. Wren AM, Small CJ, Abbott CR, Jethwa PH, Kennedy AR, Murphy KG, Stanley SA, Zollner AN, Ghatei MA & Bloom SR 2002 Hypothalamic actions of neuromedin U. Endocrinology 143 4227-4234. (doi:10.1210/ en.2002-220308)